Five-mRNA Therapy Eases Heart Failure Post-Heart Attack
Researchers at the University of Osaka have developed a therapy using five different mRNAs to treat heart failure in mice. By delivering these proteins via nanomicelles, the team successfully reduced tissue damage and improved heart function.
Why it matters
This multifactorial approach offers a potential breakthrough for treating complex heart damage that conventional single-target therapies fail to address.
Osaka, Japan - A heart attack is far from being an isolated, acute event. The consequences of an attack can cause serious and lasting damage, including heart failure. However, researchers and clinicians have been unable to determine a standardized treatment route to prevent taking long-term structural changes to the heart after a heart attack.
The article reports on scientific findings in a straightforward, objective manner without political or social framing.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in